TY - JOUR
T1 - A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
AU - Prior, Thomas W.
AU - Krainer, Adrian R.
AU - Hua, Yimin
AU - Swoboda, Kathryn J.
AU - Snyder, Pamela C.
AU - Bridgeman, Scott J.
AU - Burghes, Arthur H.M.
AU - Kissel, John T.
N1 - Funding Information:
We are grateful to all SMA families for their kind support and to all clinicians for their help in providing blood samples. We thank Michelle Hastings for sharing her unpublished data. This research was supported by grants from Families of SMA. A.R.K. and Y.H. acknowledge support from grant R01-GM42699 from the National Institute of General Medical Sciences. K.J.S. received support from the Public Health Services Research Grant, no. UL1-RR025764 and C06-RR11234, from the National Center for Research Resources, and by the NIH grant R01-HD054599-01 from the National Institute of Child Health and Human Development.
PY - 2009/9/11
Y1 - 2009/9/11
N2 - Spinal muscular atrophy (SMA) is a common autosomal-recessive motor neuron disease caused by the homozygous loss of the SMN1 gene. A nearly identical gene, SMN2, has been shown to decrease the severity of SMA in a dose-dependent manner. However SMN2 is not the sole phenotypic modifier, because there are discrepant SMA cases in which the SMN2 copy number does not explain the clinical phenotype. This report describes three unrelated SMA patients who possessed SMN2 copy numbers that did not correlate with the observed mild clinical phenotypes. A single base substitution in SMN2, c.859G>C,, was identified in exon 7 in the patients' DNA. We now show that the change creates a new exonic splicing enhancer element and increases the amount of full-length transcripts, thus resulting in the less severe phenotypes. This demonstrates that the c.859G>C substitution is a positive modifier of the SMA phenotype and that not all SMN2 genes are equivalent. We have shown not only that the SMA phenotype is modified by the number of SMN2 genes but that SMN2 sequence variations can also affect the disease severity.
AB - Spinal muscular atrophy (SMA) is a common autosomal-recessive motor neuron disease caused by the homozygous loss of the SMN1 gene. A nearly identical gene, SMN2, has been shown to decrease the severity of SMA in a dose-dependent manner. However SMN2 is not the sole phenotypic modifier, because there are discrepant SMA cases in which the SMN2 copy number does not explain the clinical phenotype. This report describes three unrelated SMA patients who possessed SMN2 copy numbers that did not correlate with the observed mild clinical phenotypes. A single base substitution in SMN2, c.859G>C,, was identified in exon 7 in the patients' DNA. We now show that the change creates a new exonic splicing enhancer element and increases the amount of full-length transcripts, thus resulting in the less severe phenotypes. This demonstrates that the c.859G>C substitution is a positive modifier of the SMA phenotype and that not all SMN2 genes are equivalent. We have shown not only that the SMA phenotype is modified by the number of SMN2 genes but that SMN2 sequence variations can also affect the disease severity.
UR - https://www.scopus.com/pages/publications/69449103716
U2 - 10.1016/j.ajhg.2009.08.002
DO - 10.1016/j.ajhg.2009.08.002
M3 - Article
C2 - 19716110
AN - SCOPUS:69449103716
SN - 0002-9297
VL - 85
SP - 408
EP - 413
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -